Joseph P. Uberti

Disabling Immune Tolerance by Programmed Death-1 Blockade With Pidilizumab After Autologous Hematopoietic Stem-Cell Transplantation for Diffuse Large B-Cell Lymphoma: Results of an International Phase II Trial

Philippe Armand, Arnon Nagler, Edie Weller et al. · Journal of Clinical Oncology · 2013 · 439 citations · Full text

Medicine, Hematology, Oncology +17

Adult Human Mesenchymal Stem Cells Added to Corticosteroid Therapy for the Treatment of Acute Graft-versus-Host Disease

Partow Kebriaei, Luis Isola, Erkut Bahceci et al. · Biology of Blood and Marrow Transplantation · 2009 · 433 citations · Full text

Pharmacy, Immunology, Cell Therapy +16

Prospective comparative trial of autologous versus allogeneic bone marrow transplantation in patients with non-Hodgkin's lymphoma

V. Ratanatharathorn, Joseph P. Uberti, Chatchada Karanes et al. · Blood · 1994 · 226 citations · Full text

Medicine, Hematology, Oncology +10

A Phase 3 Randomized Study of Remestemcel-L versus Placebo Added to Second-Line Therapy in Patients with Steroid-Refractory Acute Graft-versus-Host Disease

Partow Kebriaei, Jack Hayes, Andrew Daly et al. · Biology of Blood and Marrow Transplantation · 2019 · 201 citations · Full text

Pharmacy, Immunology, Cell Therapy +12

Treatment of chronic graft-versus-host disease with anti-CD20 chimeric monoclonal antibody

Voravit Ratanatharathorn, Lois Ayash, C. Reynolds et al. · Biology of Blood and Marrow Transplantation · 2003 · 199 citations · Full text

Life Sciences, Immunology, Pharmacotherapy +13